Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInvestec Regulatory News (INVP)

Share Price Information for Investec (INVP)

Share Price is delayed by 15 minutes
Get Live Data
629.50    4.00 (0.64%)
Bid:
624.00
Ask:
625.00
Spread: 1.00 (0.16%)
Market Cap: £3.98b
INVP Live PriceLast checked at - London Stock Exchange

Intraday Investec Share Chart

Investec Ltd Preference Share Repurchase

20 Mar 2026 15:30

RNS Number : 5384X
Investec PLC
20 March 2026
Β 

Investec Limited

Incorporated in the Republic of South Africa

Registration number 1925/002833/06

JSE share code: INL

JSE share code: INPR

JSE debt code: INLV

NSX share code: IVD

BSE share code: INVESTEC

ISIN: ZAE000081949

ISIN: ZAE000063814

LEI: 213800CU7SM6O4UWOZ70

Investec plc

Incorporated in England and Wales

Registration number 03633621

LSE share code: INVP

JSE share code: INP

ISIN: GB00B17BBQ50

LEI: 2138007Z3U5GWDN3MY22

Β 

Β 

As part of the dual listed company structure, the boards of Investec plc and Investec Limited (together the "Board") notify both the London Stock Exchange and the JSE Limited of matters which are required to be disclosed under the Disclosure Guidance and Transparency Rules, and Listing Rules of the United Kingdom Listing Authority (the "UKLA") and the JSE Listings Requirements.

Β 

The Board accordingly advises as follows:

Β 

INVESTEC LIMITED NON-REDEEMABLE, NON-CUMULATIVE, NON-PARTICIPATING PREFERENCE SHARES ("PREFERENCE SHARES") REPURCHASE

Β 

Investec Limited (the "Company") hereby advises that, in accordance with a resolution passed by the Company's board on 19 November 2025 (the "Board Resolution"), the Company may repurchase up to a maximum of 20% of the Preference Shares in issue as at the date of and pursuant to the current general authority granted by the Company's shareholders on 7 August 2025.

Β 

It was further resolved that any repurchases would, pursuant to the current general authority, be within certain pre-determined price limits with specific reference to the limits granted under the current the general authority as well as the JSE Listings Requirements.

Β 

Shareholders are herewith advised that the Company has, pursuant to the repurchase of Preference Shares announced via SENS by the Company on 10 December 2025, and in addition to the Preference Share repurchases announced via SENS by the Company on 22 January 2026, repurchased 474,493 Preference Shares from 22 January 2026 to 18Β MarchΒ 2026, Β representing 1.91% of the issued Preference Share capital as at the date of the current general authority.

Β 

This brings the total number of Preference Shares repurchased under the current general authority to 1,490,810, representing 6.00% of the issued Preference Share Capital as at the date of the current general authority. Following these repurchases, 23,345,033 Preference Shares remain in issue. The Company may repurchase a further 3,476,358 Preference Shares, being 14.00% of the Preference Shares in issue as at 7 August 2025, under the current general authority.

Β 

The Preference Shares were repurchased for an aggregate value of R47,318,733.71

Β 

Number of preference shares repurchased

Average price per Preference Share (R)

Highest price per Preference Share (R)

Lowest price per Preference Share (R)

Aggregate value (R)

474,493

99.72

100.50

99.20

47,318,733.71

Β 

The repurchases were made in terms of the current general authority and were effected through the order book on the JSE trading system without any prior understanding or arrangement between the Company and the counterparties.

Β 

To the extent not already done so, application will be made to the JSE to de-list the Preference Shares repurchased, at which point they will immediately be cancelled.

Β 

The impact of the repurchase of the Preference Shares on the financial information of the Company is immaterial. The Preference Shares were repurchased from excess cash resources of the Company; going forward, no Preference Share dividends will be payable on the repurchased Preference Shares and interest earned on the cash utilised for the repurchase will be foregone.

Β 

OPINION OF THE BOARD OF THE COMPANY

Β 

The board of the Company has considered the effect of the repurchases and is of the opinion that:

Β 

Β· The Company and the Company and its subsidiaries (the "Group") will be able, in the ordinary course of Β business, to repay their debts for a period of 12 months after the date of this announcement;

​

Β· The consolidated assets of the Company and the Group will be in excess of the consolidated liabilities of Β the Company and the Group for a period of 12 months after the date of this announcement;

​

Β· The Company's and the Group's share capital and reserves will be adequate for the purposes of the business of the Company and the Group for a period of 12 months after the date of this announcement; and

​

Β· The Company and the Group will have sufficient working capital for ordinary business purposes.

Johannesburg

20 March 2026

Sponsor

Investec Bank Limited

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCAKKBNQBKDPNB
Date   Source Headline
19th Jun 20269:56 amGNWForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
19th Jun 20269:28 amGNWForm 8.5 (EPT/RI)-Treatt Plc
19th Jun 20269:22 amGNWForm 8.5 (EPT/RI)-Gamma Communications Plc
18th Jun 20263:16 pmRNSShare Scheme Purchases
18th Jun 20262:00 pmRNSDirector/PDMR Shareholding
18th Jun 202610:20 amGNWForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
18th Jun 202610:20 amBUSForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
18th Jun 202610:14 amGNWForm 8.5 (EPT/RI)-Gamma Communications Plc
18th Jun 202610:14 amBUSForm 8.5 (EPT/RI)-Gamma Communications Plc
18th Jun 202610:12 amGNWForm 8.5 (EPT/RI)-Treatt Plc
18th Jun 202610:12 amBUSForm 8.5 (EPT/RI)-Treatt Plc
17th Jun 20263:30 pmRNSPLC, INL and IBL - Credit rating action by Fitch
17th Jun 20262:30 pmRNSDirector/PDMR Shareholding
17th Jun 202610:19 amGNWForm 8.5 (EPT/RI)-Gamma Communications Plc
17th Jun 202610:19 amBUSForm 8.5 (EPT/RI)-Gamma Communications Plc
17th Jun 202610:15 amGNWForm 8.5 (EPT/RI)-Treatt Plc
17th Jun 202610:15 amBUSForm 8.5 (EPT/RI)-Treatt Plc
17th Jun 202610:10 amGNWForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
17th Jun 202610:10 amBUSForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
16th Jun 202612:34 pmGNWForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
16th Jun 202612:34 pmBUSForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
16th Jun 20269:30 amGNWForm 8.5 (EPT/RI)-Treatt Plc
16th Jun 20269:30 amBUSForm 8.5 (EPT/RI)-Treatt Plc
16th Jun 20269:26 amGNWForm 8.5 (EPT/RI)-Gamma Communications Plc
16th Jun 20269:26 amBUSForm 8.5 (EPT/RI)-Gamma Communications Plc
15th Jun 202610:04 amGNWForm 8.5 (EPT/RI)-Gamma Communications Plc
15th Jun 202610:04 amBUSForm 8.5 (EPT/RI)-Gamma Communications Plc
15th Jun 202610:02 amGNWForm 8.5 (EPT/RI)-Treatt Plc
15th Jun 202610:02 amBUSForm 8.5 (EPT/RI)-Treatt Plc
15th Jun 202610:01 amGNWForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
15th Jun 202610:01 amBUSForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
12th Jun 202611:00 amRNSShare Scheme Purchases
12th Jun 202610:39 amGNWForm 8.5 (EPT/RI)-Treatt Plc
12th Jun 202610:39 amBUSForm 8.5 (EPT/RI)-Treatt Plc
12th Jun 202610:36 amGNWForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
12th Jun 202610:36 amBUSForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
12th Jun 202610:31 amGNWForm 8.5 (EPT/RI)-Gamma Communications Plc
12th Jun 202610:31 amBUSForm 8.5 (EPT/RI)-Gamma Communications Plc
11th Jun 202611:10 amGNWForm 8.5 (EPT/RI)-Gamma Communications Plc
11th Jun 202611:10 amBUSForm 8.5 (EPT/RI)-Gamma Communications Plc
11th Jun 202611:04 amGNWForm 8.5 (EPT/RI)-NCC Group Plc
11th Jun 202611:04 amBUSForm 8.5 (EPT/RI)-NCC Group Plc
11th Jun 202610:59 amGNWForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
11th Jun 202610:59 amBUSForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
11th Jun 202610:55 amGNWForm 8.5 (EPT/RI)-Treatt Plc
11th Jun 202610:55 amBUSForm 8.5 (EPT/RI)-Treatt Plc
10th Jun 20262:00 pmRNSDirector/PDMR Shareholding
10th Jun 20269:38 amGNWForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
10th Jun 20269:38 amBUSForm 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
10th Jun 20269:32 amGNWForm 8.5 (EPT/RI)-NCC Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.